Highly purified and functionally stable <i>in vitro</i> expanded allospecific Tr1 cells expressing immunosuppressive graft-homing receptors as new candidates for cell therapy in solid organ transplantation.

Front Immunol · 2023 · PMC9998667 · PMID 36911743

Europe PMC DOI

hedged sentence

0.0940

closest p · 1.9× alpha

0.0940

boldest claim

The sentences

showed a trendp=0.0940so close (0.05 < p ≤ 0.1)

On the other hand, expression of CXCR3 and CCR4 showed a trend towards a decrease in Exp-allo Tr1 cells compared to T conv cells (CXCR3 60.3% ± 25.51 vs 86.30% ± 7.7, p=0.0940 ; CCR4 60.3% ± 9.7 vs 93.2% ± 5.2, p=0.0759 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.